Abrdn World Healthcare Fund (THW)
$12.55
Performance
- $12.53$12.67$12.55
0.16%
Downside
Day's Volatility :1.1%
Upside
0.95%
- $9.22$13.24$12.55
26.53%
Downside
52 Weeks Volatility :30.36%
Upside
5.21%
Returns
| Period | Abrdn World Healthcare Fund | Russel 2000 | Index (Russel 2000) |
|---|---|---|---|
3 Months | -0.32% | 0.0% | 0.0% |
6 Months | 18.85% | 0.0% | 0.0% |
1 Year | -11.82% | 1.3% | 1.3% |
3 Years | -20.24% | -22.1% | -22.1% |
Highlights
Analyst Recommendation
Technicals Summary
Sell
Neutral
Buy
Abrdn World Healthcare Fund is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Abrdn World Healthcare Fund | -2.4% | 18.85% | -11.82% | -20.24% | 0.4% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Abrdn World Healthcare Fund | NA | NA | NA | NA | NA | NA | NA | NA |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Abrdn World Healthcare Fund | NA | $481.8M | 0.4% | NA | NA |
Corporate Announcements
Abrdn World Healthcare Fund Earnings
Abrdn World Healthcare Fund’s price-to-earnings ratio stands at None
Read More
Company Information
tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form
Organization | Abrdn World Healthcare Fund |
Employees | 4 |
CEO | |
Industry | Miscellaneous |
